跳至主要内容
临床试验/PACTR202303797356166
PACTR202303797356166尚未招募2 期

Sildenafil citrate to improve maternal and neonatal outcomes in low-resource settings: a randomized feasibility trial

niversity of Alabama at Birmingman0 个研究点目标入组 500 人开始时间: 2023年3月17日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • ?Pregnant women presenting in early labor with a term pregnancy (=37 weeks gestation)
  • oEarly labor will be defined as cervical dilation less than or equal to 6 cm
  • oGestational age will be calculated from the most reliable variable using the following hierarchy of reliability: 1) gestational dating ultrasound completed at any time during the pregnancy (with preference to the earliest exam), 2) date of last menstrual period if menses are regular
  • ?Planned vaginal delivery
  • ?Maternal age 18-50 years or an emancipated minor according to local standards
  • ?A single, live fetus in cephalic presentation confirmed prior to randomization

排除标准

  • ?Unknown gestational age
  • ?Maternal history of caesarian delivery
  • ?Maternal contraindication to sildenafil therapy such as hypersensitivity to nitrates or nitrites
  • ?Recognized fetal anomaly
  • ?Any maternal medical condition or status that precludes informed consent

研究者

发起方
niversity of Alabama at Birmingman

相似试验